Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Multiple sclerosis: antibodies can initiate the inflammation at the core of the disease


Two research groups, one from the Institute of Neuroimmunology / Institute for Multiple Sclerosis Research (IMSF) and the other from the Institute of Neuropathology / Department of Neurology, all belonging to the University Medical Center Göttingen (UMG), have made a similar discovery independently using an animal model of multiple sclerosis: a new mechanism involving so-called autoantibodies that initiates and aggravates inflammatory CNS disease. This discovery contributes towards understanding what factors bring about multiple sclerosis and, by extension, potential diagnostic and therapeutic options.

Two research groups, one from the Institute of Neuroimmunology / Insti-tute for (UMG), have made a similar discovery independently using an animal model of multiple Multiple Sclerosis Research (IMSF) and the other from the Institute of Neuropathology / Department of Neurology, all belonging to the University Medical Center Göttingen sclerosis: a new mechanism involving so-called autoantibodies that initiates and aggravates inflammatory CNS disease.

Autoantibodies are concentrated in scavenger cells situated in the meninges

Source: umg

This discovery contributes towards understanding what factors bring about multiple sclerosis and, by extension, potential diagnostic and therapeutic op-tions. Publications in the journals “Proceedings of the National Academy of Sciences USA” and “Acta Neuropathologica”.

Original publications: Anne-Christine Flach, Tanja Litke, Judith Strauss, Michael Haberl, César Cordero Gómez, Markus Reindl, Albert Saiz, Hans Jörg Fehling, Jürgen Wienands, Francesca Odoardi, Fred Lühder & Alexander Flügel. Autoanti-body-boosted T cell re-activation in the target organ triggers manifestation of auto-immune CNS disease. Proc. Nat. Acad Sci USA (2016) 13: 3323-3328.

Silke Kinzel, Klaus Lehmann-Horn, Sebastian Torke, Darius Häusler, Anne Winkler, Christine Stadelmann, Natalie Payne, Linda Feldmann, Albert Saiz, Markus Reindl, Patrice H. Lalive, Claude C. Bernard, Wolfgang Brück & Martin S. Weber. Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen. Acta Neuropathol. (2016)
DOI: 10.1007/s00401-016-1559-8

The current understanding of the disease multiple sclerosis is that it is an autoimmune disease, i.e. it is triggered by a sub-group of the body’s own immune cells, so-called T cells. T cells coordinate our immune response and in a healthy person are responsible for defending the body against pathogens and abnormal tumor cells. In the case of multiple sclerosis, a number of T cells mistakenly identify healthy brain tissue as foreign and thereupon start an immune attack against the body’s own central nervous system (CNS).

The collateral damage of this attack is the destruction of nervous tissue, leading to the neurological deficits well-known in multiple sclerosis such as paralysis and somatosensory defects. Why of all things would our T cells attack the brain, a part of the body usually possessing a highly-efficient defense system and sealed off from immune cells? This important question, at the basis of the cause of multiple sclerosis, is as yet largely unanswered. Göttingen researchers have now discovered an immune mechanism that could explain exactly why T cells may focus on brain tissue and then spark off an immune reaction.

Interestingly, our T cells cannot react directly to foreign intruders. Before a T cell activation can take place, with all its potential dramatic consequences, nature has devised an extra control step that must first occur, which is that firstly potential pathogens (e.g. bacteria, tumor cells) must be taken up and digested by scavenger cells. These scavenger cells determine at this stage whether the ingested material could be problematic or is harmless.

The digested “remains”, so-called peptides, are presented to T cells via certain molecules situated on the scavenger cells’ surface. If it is a case of potentially harmful material, then those T cells that recognize the specific peptides in question become activated and raise an alarm. If, however, there is no danger, the T cells do not become activated. Of course the latter should occur if the material in question is the body’s own tissue. Even a healthy body has some T cells that potentially react against the body’s own tissue, but they won’t become activated and cause an immune attack without also receiving the relevant alarm signals.

How is the situation different in multiple sclerosis? The Göttingen researchers discovered that an additional component of the immune system, namely antibodies produced by B cells, play an important role in how brain tissue is taken up by scavenger cells. Antibodies can move freely in bodily fluid, untied to cells. As with T cells, there are some antibodies that target the body’s own tissue, so-called autoantibodies.

These can bind directly to their target natural body tissue. The Göttingen researchers found that in a model of multiple sclerosis where T cells are present that potentially target brain tissue, only the addition of brain tissue-targeting autoantibodies produced a strong activation of the T cells and the resultant fulminant CNS inflammation.

Hereby the autoantibodies bound cell fragments with the relevant target-recognizing structures. As the Göttingen researchers could demonstrate in different model situations, the structures decorated with autoantibodies were eagerly taken up by scavenger cells and, after being digested, presented as self-peptides to T cells. The autoantibodies therefore significantly influenced T cell recognition of the body’s own tissue and their subsequent activation.

Autoantibodies can therefore act as a kind of marker that makes fragments of the body’s own tissue “palatable” to scavenger cells searching in the vicinity. At the same time the autoantibodies also function as “collectors”, because they concentrate in the scavenger cells the number of relatively scarce fragments of the body’s own brain tissue captured by them.


The results of this research make clear that autoantibodies can initiate and aggravate the inflammatory process in the nervous system by concentrating the body’s own structures in scavenger cells and thus making them visible to T cells. B cells and autoantibodies have come into focus in multiple sclerosis research, because a therapy targeting B cells has shown remarkable efficacy in treating sufferers of multiple sclerosis. Certainly, though, the exact mechanism by which B cells and autoantibodies play a role in the pathogenesis of multiple sclerosis and therefore the explanation for why the therapy is successful could not be explained.

Up until now it has been assumed that autoantibodies damage tissue structures directly by further destroying already inflamed tissue structures and thereby aggravate a manifest disease. The Göttingen researchers’ data do not rule out this possibility. However, the data points to an additional role for autoantibodies in initiating in multiple sclerosis, a significant piece of knowledge for diagnostic and, above all, therapeutic approaches.

For example, the presence of certain autoantibodies could indicate a risk of an impending acute disease episode and allow specific protective measures to be set in place to avoid it. The key therapeutic potential of the research results surely lie in the fact that the specific group of patients who possess autoantibodies should probably receive a therapy targeting these autoantibodies. This is significant, because the majority of available therapy options in MS target T cells, thus not fighting or not fighting sufficiently strongly the other initiators of the disease.

CAPTION: Autoantibodies are concentrated in scavenger cells situated in the meninges
This real-time microscopic image shows autoantibodies (magenta, autoantibodies specific to the myelin oligodendrocyte glycoprotein (MOG)) binding to scavenger cells (green, CX3CR1 + GFP+ cells) in the meninges. The latter are scattered around blood vessels (red, labelled with the Dextran Texas Red). Scale of overview 50µM, enlarged segment : 20µM. Source: umg

University Medical Center Göttingen, Georg-August University

Institute of Neuroimmunoloy / Institute for Multiple Sclerosis Research
Alexander Flügel, MD, and Fred Lühder, PhD
Phone +49 (0) 551 / 39-13332,

Institute of Neuropathologie / Department of Neurology
Martin S. Weber, MD
Phone +49 () 0551 / 39-12700,

Stefan Weller | idw - Informationsdienst Wissenschaft
Further information:

More articles from Life Sciences:

nachricht A Map of the Cell’s Power Station
18.08.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau

nachricht On the way to developing a new active ingredient against chronic infections
18.08.2017 | Deutsches Zentrum für Infektionsforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>



Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

More VideoLinks >>>